Application no. and date | 98961833.5 (espacenet) (Federated) (European Patent Register), 19981130 | Patent/reg. no. and date | DK/EP 1033996, 20080625 | Publication date | 20000913 | Priority no. and date | US 67740 P, 19971202, US 80970 P, 19980407 | EP pub. no. and date |
EP 1033996 20000913 | Effective date | | Applicant/owner | Janssen Alzheimer Immunotherapy, Little Island Industrial Estate
Little Island, County Cork, IE | Applicant ref. no. | 133738 | Inventor | SCHENK, Dale, B., 1542 Los Altos Drive
Burlingame, CA 94010-5941, US | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | Opponent | | IPC Class | A61K 33/06 (2006.01) , A61K 38/00 (2006.01) , A61K 38/28 (2006.01) , A61K 9/26 (2006.01) , A61P 25/28 (2006.01) | Title | Forebyggelse og behandling af amyloidogen sygdom | Int. application no. | US1998025386 | Int. publication no. | WO1999027944 | Related patent (certificate) | | Status | Ophævet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|